Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib
…, A Maieron, R Königsberg, R Stauber, B Grünberger… - Radiology, 2012 - pubs.rsna.org
Purpose To compare the efficacies of transarterial chemoembolization (TACE) and sorafenib
in patients with advanced-stage hepatocellular carcinoma (HCC). Materials and Methods …
in patients with advanced-stage hepatocellular carcinoma (HCC). Materials and Methods …
Antibiotic Treatment Is Not Effective in Patients Infected With Helicobacter pylori Suffering From Extragastric MALT Lymphoma
B Grünberger, S Wöhrer, B Streubel… - Journal of clinical …, 2006 - ascopubs.org
Purpose Apart from anecdotal reports implicating Helicobacter pylori (HP) in the development
of extragastric mucosa associated lymphoid tissue (MALT) lymphoma, no large scale …
of extragastric mucosa associated lymphoid tissue (MALT) lymphoma, no large scale …
Neoadjuvant chemotherapy with gemcitabine plus cisplatin in patients with locally advanced bladder cancer
D Niedersüss-Beke, T Puntus, T Kunit, B Grünberger… - Oncology, 2017 - karger.com
Background: Neoadjuvant chemotherapy with methotrexate-vinblastine-doxorubicin-cisplatin
(MVAC) is the standard of care for muscle-invasive urothelial bladder cancer. Gemcitabine …
(MVAC) is the standard of care for muscle-invasive urothelial bladder cancer. Gemcitabine …
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy–An Update
…, W Eisterer, A Gerger, B Grünberger… - Anticancer …, 2023 - ar.iiarjournals.org
Over the last decade, therapeutic options for patients with gastric cancer have improved
significantly. However, despite these recent advances, mortality is still substantial. Surgery and …
significantly. However, despite these recent advances, mortality is still substantial. Surgery and …
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
…, HG Derigs, P Bohanes, B Grünberger… - Journal of Geriatric …, 2023 - Elsevier
Introduction Colorectal cancer (CRC) mainly affects older patients. The pivotal VELOUR
phase III trial of aflibercept plus FOLFIRI in metastatic CRC (mCRC) included only 5.9% of …
phase III trial of aflibercept plus FOLFIRI in metastatic CRC (mCRC) included only 5.9% of …
REGO-ACT: assessment of physical activity during treatment with regorafenib for metastatic colorectal cancer
G Piringer, L Vormittag, L Öhler, B Grünberger… - Wiener klinische …, 2020 - Springer
Background A frequent side effect of the multikinase inhibitor regorafenib is fatigue.
Physical activity has shown potential in reducing cancer-related fatigue. Methods This non-…
Physical activity has shown potential in reducing cancer-related fatigue. Methods This non-…
Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine
…, PM Putora, B Grünberger… - Therapeutic …, 2019 - journals.sagepub.com
Background: The management of patients with metastatic pancreatic cancer (mPC) is
challenging, and the optimal treatment strategy is debated among experts. In an attempt to identify …
challenging, and the optimal treatment strategy is debated among experts. In an attempt to identify …
[HTML][HTML] Real-world evaluation of quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer: the prospective …
RD Hofheinz, S Anchisi, B Grünberger, HG Derigs… - Cancers, 2022 - mdpi.com
Simple Summary Colorectal cancer (CRC) is the third most frequently diagnosed malignancy
worldwide and the second leading cause of cancer-related mortality. In VELOUR phase III …
worldwide and the second leading cause of cancer-related mortality. In VELOUR phase III …
[HTML][HTML] Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
…, G Pfeiler, M Gnant, B Grünberger… - Wiener klinische …, 2022 - Springer
In the past 12 months a plethora of relevant novel data for the treatment of metastatic HER2
positive breast cancer were published. To bring this new evidence into a clinical perspective, …
positive breast cancer were published. To bring this new evidence into a clinical perspective, …
Systemische Therapie des Nierenzellkarzinoms–aktuelle Behandlungsmöglichkeiten
B Grünberger - Wiener Medizinische Wochenschrift, 2011 - infona.pl
Das Nierenzellkarzinom ist die häufigste Form der malignen Nierentumoren. Zu den wichtigsten
exogenen Risikofaktoren zählen der Nikotinabusus sowie die Adipositas. Oft wird das …
exogenen Risikofaktoren zählen der Nikotinabusus sowie die Adipositas. Oft wird das …